Shorter GT repeats in the heme oxygenase-1 gene promoter are associated with a lower severity score in coronary artery disease

Journal of the Chinese Medical Association

Volumn 76, Issue 6, 2013, Pages 312-318

  Liang, Kae Woei ^a,b,c,d   Sheu, Wayne H H ^a,b,c,e   Lee, Wen Lieng ^a,b   Lee, I Te ^a,b,c   Lin, Shih Yi ^a,b   Ting, Chih Tai ^a,b   Lee, Wen Jane ^a,f  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^f TUNGHAI UNIVERSITY   (Taiwan)

Author keywords

Coronary artery disease; Heme oxygenase 1; Polymorphism

Indexed keywords

GLUTATHIONE; HEME OXYGENASE 1; THYMIDINE;

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; DINUCLEOTIDE REPEAT; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HUMAN; INJURY SCALE; JEOPARDY SCORING SYSTEM; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PROMOTER REGION;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HEME OXYGENASE-1; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; REPETITIVE SEQUENCES, NUCLEIC ACID; SEVERITY OF ILLNESS INDEX;

EID: 84878236401     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2013.03.005     Document Type: Article

References (34)

1. Idriss N.K., Blann A.D., Lip G.Y. Hemoxygenase-1 in cardiovascular disease. J Am Coll Cardiol 2008, 52:971-978.
2. Furchgott R.F., Jothianandan D. Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels 1991, 28:52-61.
3. Dulak J., Deshane J., Jozkowicz A., Agarwal A. Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation 2008, 117:231-241.
4. Lin C.C., Yang W.C. Prognostic factors influencing the patency of hemodialysis vascular access: literature review and novel therapeutic modality by far infrared therapy. J Chin Med Assoc 2009, 72:109-116.
5. Chen Y.H., Lin S.J., Lin M.W., Tsai H.L., Kuo S.S., Chen J.W., et al. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 2002, 111:1-8.
6. Exner M., Schillinger M., Minar E., Mlekusch W., Schlerka G., Haumer M., et al. Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty. J Endovasc Ther 2001, 8:433-440.
7. Bai C.H., Chen J.R., Chiu H.C., Chou C.C., Chau L.Y., Pan W.H. Shorter GT repeat polymorphism in the heme oxygenase-1 gene promoter has protective effect on ischemic stroke in dyslipidemia patients. J Biomed Sci 2010, 17:12.
8. Bao W., Song F., Li X., Rong S., Yang W., Wang D., et al. Association between heme oxygenase-1 gene promoter polymorphisms and type 2 diabetes mellitus: a HuGE review and meta-analysis. Am J Epidemiol 2010, 172:631-636.
9. Chen Y.H., Chau L.Y., Lin M.W., Chen L.C., Yo M.H., Chen J.W., et al. Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with angiographic restenosis after coronary stenting. Eur Heart J 2004, 25:39-47.
10. Kaneda H., Ohno M., Taguchi J., Togo M., Hashimoto H., Ogasawara K., et al. Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vasc Biol 2002, 22:1680-1685.
11. Dick P., Schillinger M., Minar E., Mlekusch W., Amighi J., Sabeti S., et al. Haem oxygenase-1 genotype and cardiovascular adverse events in patients with peripheral artery disease. Eur J Clin Invest 2005, 35:731-737.
12. Lublinghoff N., Winkler K., Winkelmann B.R., Seelhorst U., Wellnitz B., Boehm B.O., et al. Genetic variants of the promoter of the heme oxygenase-1 gene and their influence on cardiovascular disease (the Ludwigshafen Risk and Cardiovascular Health study). BMC Med Genet 2009, 10:36.
13. Tiroch K., Koch W., von Beckerath N., Kastrati A., Schomig A. Heme oxygenase-1 gene promoter polymorphism and restenosis following coronary stenting. Eur Heart J 2007, 28:968-973.
14. Califf R.M., Phillips H.R., Hindman M.C., Mark D.B., Lee K.L., Behar V.S., et al. Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol 1985, 5:1055-1063.
15. Gensini G.G. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983, 51:606.
16. Serruys P.W., Morice M.C., Kappetein A.P., Colombo A., Holmes D.R., Mack M.J., et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009, 360:961-972.
17. Wang M.H., Lee W.L., Wang K.Y., Hsieh Y.C., Liu T.J., Lin I.H., et al. Short-term follow-up results of drug-eluting stenting in premature coronary artery disease patients with multiple atherosclerotic risk factors. J Chin Med Assoc 2008, 71:342-346.
18. Sanborn T.A., Sleeper L.A., Webb J.G., French J.K., Bergman G., Parikh M., et al. Correlates of one-year survival inpatients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trial. J Am Coll Cardiol 2003, 42:1373-1379.
19. Ellis S.G., Roubin G.S., King S.B., Douglas J.S., Shaw R.E., Stertzer S.H., et al. In-hospital cardiac mortality after acute closure after coronary angioplasty: analysis of risk factors from 8,207 procedures. J Am Coll Cardiol 1988, 11:211-216.
20. Liang K.W., Lee W.J., Lee W.L., Ting C.T., Sheu W.H. Decreased ratio of high-molecular-weight to total adiponectin is associated with angiographic coronary atherosclerosis severity but not restenosis. Clin Chim Acta 2009, 405:114-118.
21. Lee W.L., Lee W.J., Chen Y.T., Liu T.J., Liang K.W., Ting C.T., et al. The presence of metabolic syndrome is independently associated with elevated serum CD40 ligand and disease severity in patients with symptomatic coronary artery disease. Metabolism 2006, 55:1029-1034.
22. Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000, 342:145-153.
23. The H.O.P.E. study investigators. The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. Can J Cardiol 1996, 12:127-137.
24. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837-1847.
25. Ishikawa K., Navab M., Leitinger N., Fogelman A.M., Lusis A.J. Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J Clin Invest 1997, 100:1209-1216.
26. Siow R.C., Sato H., Mann G.E. Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide?. Cardiovasc Res 1999, 41:385-394.
27. Morita T., Kourembanas S. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J Clin Invest 1995, 96:2676-2682.
28. Terry C.M., Clikeman J.A., Hoidal J.R., Callahan K.S. Effect of tumor necrosis factor-alpha and interleukin-1 alpha on heme oxygenase-1 expression in human endothelial cells. Am J Physiol 1998, 274:H883-H891.
29. Cavalca V., Veglia F., Squellerio I., Marenzi G., Minardi F., De Metrio M., et al. Glutathione, vitamin E and oxidative stress in coronary artery disease: relevance of age and gender. Eur J Clin Invest 2009, 39:267-272.
30. Song J., Sumiyoshi S., Nakashima Y., Doi Y., Iida M., Kiyohara Y., et al. Overexpression of heme oxygenase-1 in coronary atherosclerosis of Japanese autopsies with diabetes mellitus: Hisayama study. Atherosclerosis 2009, 202:573-581.
31. Morsi W.G., Shaker O.G., Ismail E.F., Ahmed H.H., El-Serafi T.I., Maklady F.A., et al. HO-1 and VGEF gene expression in human arteries with advanced atherosclerosis. Clin Biochem 2006, 39:1057-1062.
32. Chen S.M., Li Y.G., Wang D.M., Zhang G.H., Tan C.J. Expression of heme oxygenase-1, hypoxia inducible factor-1alpha, and ubiquitin in peripheral inflammatory cells from patients with coronary heart disease. Clin Chem Lab Med 2009, 47:327-333.
33. Chen S.M., Li Y.G., Wang D.M. Study on changes of heme oxygenase-1 expression in patients with coronary heart disease. Clin Cardiol 2005, 28:197-201.
34. Idriss N.K., Lip G.Y., Balakrishnan B., Jaumdally R., Boos C.J., Blann A.D. Plasma haemoxygenase-1 in coronary artery disease. A comparison with angiogenin, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor. Thromb Haemost 2010, 104:1029-1037.